- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on PTEN Hamartoma Tumor Syndrome
Total 811 results
-
Stanford UniversityNot yet recruitingPTEN Gene Mutation | PTEN Hamartoma Tumor Syndrome | PTEN Hamartoma SyndromeUnited States
-
University of South FloridaBoston Children's HospitalCompletedPTEN Gene MutationUnited States
-
Boston Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedPTEN Gene Mutation | PTEN Hamartoma Tumor SyndromeUnited States
-
John Carroll UniversityUniversity Hospital Southampton NHS Foundation TrustActive, not recruitingPTEN Hamartoma Tumor SyndromeUnited States, United Kingdom
-
Radboud University Medical CenterUnknownPTEN Hamartoma Tumor Syndrome
-
Ohio State UniversityPfizer; PTEN ResearchActive, not recruitingCowden Syndrome | Polyposis | PTEN Gene Mutation | PTEN Hamartoma Tumor Syndrome | PTEN Hamartoma Syndrome | Bannayan Syndrome | Bannayan Zonana SyndromeUnited States
-
Boston Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingAutism | ASD | Macrocephaly | PTEN | PTEN Hamartoma Tumor SyndromeUnited States
-
Deborah DoroshowRecruitingPTEN-null Advanced Solid TumorsUnited States
-
Faeth TherapeuticsActive, not recruitingAdvanced Solid Tumor | PIK3CA Mutation | PTEN Loss of Function MutationUnited States
-
Novartis PharmaceuticalsCompletedBreast Cancer | Solid Tumors | Cowden SyndromeUnited States, Spain, Canada
-
National Cancer Institute (NCI)CompletedHamartoma Syndrome, Multiple | Cowden's DiseaseUnited States
-
Novartis PharmaceuticalsCompletedBreast Cancer | Advanced Solid Tumors | Cowden SyndromeNetherlands, Spain, Germany, United Kingdom, United States
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
St. Jude Children's Research HospitalRecruitingPancreatic Cancer | Hodgkin Lymphoma | Lynch Syndrome | Tuberous Sclerosis | Fanconi Anemia | AML | Non Hodgkin Lymphoma | Familial Adenomatous Polyposis | Acute Leukemia | Nevoid Basal Cell Carcinoma Syndrome | Neurofibromatosis Type 1 | Neuroblastoma | Retinoblastoma | MDS | Rhabdomyosarcoma | Von Hippel-Lindau Disease | Adrenocortical Carcinoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingCarcinoid Tumor | Carcinoid Syndrome | Metastatic Carcinoid Tumor | Digestive System Neuroendocrine Tumor G1United States
-
National Human Genome Research Institute (NHGRI)Recruiting
-
National Human Genome Research Institute (NHGRI)CompletedProteus SyndromeUnited States
-
Crinetics Pharmaceuticals Inc.Active, not recruitingCarcinoid Tumor | Carcinoid Syndrome | Carcinoid | Carcinoid Tumor of Ileum | Carcinoid Tumor of Cecum | Carcinoid Syndrome Diarrhea | Carcinoid Intestine Tumor | Carcinoid Tumor of Liver | Carcinoid Tumor of PancreasUnited States, Brazil, Argentina, Canada, Mexico, Peru, Poland
-
Merck Sharp & Dohme LLCActive, not recruitingPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)United States, Australia, Brazil, Italy, United Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Worldwide Clinical TrialsTerminatedPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus SyndromeUnited States, Australia, Italy, Spain
-
University of EdinburghNHS Lothian; British Heart FoundationCompletedAortic Dissection | Acute Aortic Syndrome | Penetrating Aortic Ulcer | Intramural HematomaUnited Kingdom
-
Rush University Medical CenterEmory UniversityEnrolling by invitationTuberous Sclerosis | Fragile X Syndrome | Rett Syndrome | Hamartoma Syndrome, Multiple | Angelman Syndrome | Creatine Deficiency, X-linked | Telomeric 22Q13 Monosomy Syndrome | Chromosome 15Q, Partial DeletionUnited States
-
Vanderbilt-Ingram Cancer CenterEntrinsic Bioscience Inc.TerminatedNeuroendocrine Tumor | Carcinoid SyndromeUnited States
-
National Cancer Institute (NCI)RecruitingPleuropulmonary Blastoma | Cystic Nephroma | Nasal Chondromesenchymal Hamartoma | Ovarian Sertoli-Leydig Cell Tumors | Ocular MedulloepitheliomaUnited States
-
National Human Genome Research Institute (NHGRI)Children's National Research Institute; Uniformed Services University of the...RecruitingProteus Syndrome | PIK3CA Related Overgrowth SpectrumUnited States
-
National Human Genome Research Institute (NHGRI)CompletedCoronary Artery Disease | Proteus Syndrome | Familial Isolated Hyperparathyroidism | Coffin - Sins Syndrome | Dubouitz SyndromeUnited States
-
Jazz PharmaceuticalsRecruitingTuberous Sclerosis Complex | Dravet Syndrome | Lennox Gastaut SyndromeUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...No longer availableGrowth Disorders | Proteus Syndrome | PIK3CA-Related Overgrowth Spectrum (PROS)
-
Jagiellonian UniversityCompletedCushing's Syndrome | Pheochromocytoma | Adrenal Tumor | Conn's SyndromePoland
-
Royal Marsden NHS Foundation TrustRecruitingLynch Syndrome | Familial Adenomatous Polyposis | Hereditary Diffuse Gastric Cancer | Peutz-Jeghers Syndrome | Cowden Syndrome | Li Fraumeni Syndrome | MutYH-associated Polyposis | SMAD4 Gene MutationUnited Kingdom
-
National Cancer Institute (NCI)CompletedMetastatic Gastrointestinal Carcinoid Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Regional Gastrointestinal Carcinoid TumorUnited States
-
NYU Langone HealthWithdrawnEpilepsy | Tuberous Sclerosis | Dravet Syndrome | Focal Seizures | Lennox-Gastaut SyndromeUnited States
-
Lowell Anthony, MDEntrinsic Bioscience Inc.CompletedDiarrhea | Neuroendocrine Tumors | Carcinoid Syndrome | Carcinoid Tumor of GI SystemUnited States
-
Ascyrus Medical LLC.Artivion Inc.Active, not recruiting
-
IpsenTerminatedCarcinoid SyndromeSpain, Belgium, Ireland, Czechia, Israel, France, United Kingdom, Latvia, Germany, Russian Federation, Slovakia, Italy, Netherlands, Finland, Austria, Poland, Sweden, Ukraine
-
IpsenTerminatedMalignant Carcinoid SyndromeUnited States
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeGermany, United Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompleted
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedIslet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic SyndromeUnited States
-
Federation Francophone de Cancerologie DigestiveCompletedIslet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic Syndrome
-
University of California, San FranciscoSanofi; Genentech, Inc.TerminatedLung Cancer | Neuroendocrine Tumor | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic SyndromeUnited States
-
University of Wisconsin, MadisonRecruitingAcute Myeloid Leukemia | Hodgkin Lymphoma | Osteosarcoma | Acute Lymphoblastic Leukemia | Ewing Sarcoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Neuroblastoma | Rhabdomyosarcoma | Primitive Neuroectodermal Tumor | Myeloproliferative SyndromeUnited States
-
IpsenCompletedCarcinoid SyndromeUnited States, Turkey, Brazil, India, Ukraine, South Africa, Czechia, Latvia, Poland, Russian Federation, Serbia
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Spain, Sweden, United Kingdom
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, Canada, France, Germany, Israel, Spain, Sweden, United Kingdom, Netherlands
-
Endo PharmaceuticalsTerminatedCarcinoid SyndromeUnited States
-
Lexicon PharmaceuticalsCompleted
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Canada, Israel
-
Boston Medical CenterAmgenWithdrawn